Ambagon Therapeutics Launches With $85 Million Series A To Advance Pioneering Molecular Glue Platform And Progress Pipeline
Amount Raised
$85 Million
Round Type
Series A
San FranciscoBiotechnologyDescription
Ambagon Therapeutics, a biotechnology company unlocking intrinsically disordered proteins and other difficult-to-target protein classes, today announced an $85 million Series A to augment its drug discovery platform and to advance its pipeline of molecular glues.
Quick answer
Ambagon Therapeutics raised $85 Million in a Series A round, dated January 6, 2022. Ambagon Therapeutics is based in San Francisco, California, United States.
- How much did Ambagon Therapeutics raise?
- Ambagon Therapeutics raised $85 Million in a Series A round on January 6, 2022.
- What does Ambagon Therapeutics do?
- Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
- Where is Ambagon Therapeutics based and how big is it?
- Ambagon Therapeutics is based in San Francisco, California, United States. Fundz records about 28 employees.
- Who are the decision-makers at Ambagon Therapeutics?
- Fundz holds 1 contact at Ambagon Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Ambagon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Synthego Corp raised $200M (Funding Round) on February 17, 2022.
- Confluent Medical raised an undisclosed amount on February 17, 2022.
- Seer raised $15M (Series B) on February 17, 2022.
- Neo Medical raised $21M (Funding Round) on February 17, 2022.
- Classiq raised $33M (Funding Round) on February 17, 2022.
- Rubi Laboratories raised $4.5M (Seed) on February 17, 2022.
Who to call at Ambagon Therapeutics, and when
A new round usually means Ambagon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ambagon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ambagon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ambagon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ambagon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAmbagon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.